|
|
Other links at Articles > Hematology-Oncology |
| 3. |
FDA Safety Changes: Campath and Trileptal
|
|
|
The FDA has approved revisions to the safety labeling for alemtuzumab intravenous injection (Campath) and oxcarbazepine tablets/oral suspension (Trileptal). Medscape Medical News
|
| 4. |
A Case of Synchronous Bilateral Testicular Seminoma
|
|
|
Bilateral synchronous testicular tumors are rare but may require different management from what is routine for unilateral tumors. The current case report features a literature review that examines the best practice for the management of bilateral testicular tumors. Nature Clinical Practice Urology
|
|
|